Johnson & Johnson (JNJ)
152.67
+1.29
(+0.85%)
USD |
NYSE |
May 15, 16:00
152.34
-0.33
(-0.22%)
After-Hours: 20:00
Johnson & Johnson Cash from Operations (Quarterly): 3.657B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.657B |
December 31, 2023 | 7.863B |
September 30, 2023 | 7.489B |
June 30, 2023 | 4.182B |
March 31, 2023 | 3.257B |
December 31, 2022 | 5.35B |
September 30, 2022 | 6.284B |
June 30, 2022 | 5.581B |
March 31, 2022 | 3.979B |
December 31, 2021 | 5.732B |
September 30, 2021 | 8.29B |
June 30, 2021 | 5.314B |
March 31, 2021 | 4.074B |
December 31, 2020 | 8.343B |
September 30, 2020 | 8.383B |
June 30, 2020 | 3.452B |
March 31, 2020 | 3.358B |
December 31, 2019 | 6.398B |
September 30, 2019 | 7.527B |
June 30, 2019 | 5.948B |
March 31, 2019 | 3.543B |
December 31, 2018 | 6.244B |
September 30, 2018 | 6.272B |
June 30, 2018 | 6.079B |
March 31, 2018 | 3.606B |
Date | Value |
---|---|
December 31, 2017 | 6.105B |
September 30, 2017 | 6.266B |
June 30, 2017 | 5.772B |
March 31, 2017 | 2.913B |
December 31, 2016 | 6.653B |
September 30, 2016 | 5.361B |
June 30, 2016 | 4.564B |
March 31, 2016 | 2.189B |
December 31, 2015 | 5.085B |
September 30, 2015 | 6.14B |
June 30, 2015 | 5.472B |
March 31, 2015 | 2.872B |
December 31, 2014 | 4.604B |
September 30, 2014 | 4.654B |
June 30, 2014 | 5.529B |
March 31, 2014 | 3.923B |
December 31, 2013 | 4.139B |
September 30, 2013 | 5.947B |
June 30, 2013 | 5.051B |
March 31, 2013 | 2.277B |
December 31, 2012 | 3.376B |
September 30, 2012 | 4.98B |
June 30, 2012 | 4.245B |
March 31, 2012 | 2.795B |
December 31, 2011 | 3.451B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
3.257B
Minimum
Mar 2023
8.383B
Maximum
Sep 2020
5.723B
Average
5.656B
Median
Cash from Operations (Quarterly) Benchmarks
Amgen Inc | 689.00M |
Eli Lilly and Co | 1.166B |
Merck & Co Inc | 3.09B |
Pfizer Inc | 1.09B |
Shockwave Medical Inc | 35.84M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -464.00M |
Cash from Financing (Quarterly) | 546.00M |
Free Cash Flow | 18.23B |
Free Cash Flow Per Share (Quarterly) | 1.173 |
Free Cash Flow to Equity (Quarterly) | -1.45B |
Free Cash Flow to Firm (Quarterly) | 2.85B |
Free Cash Flow Yield | 4.76% |